We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
10 Year Est. Return
AUM
$310M
AUM Growth
+$60.3M
Cap. Flow
+$49M
Cap. Flow %
15.81%
Top 10 Hldgs %
7.4%
Holding
817
New
340
Increased
127
Reduced
80
Closed
270

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$2.34M
2
PCG icon
PG&E
PCG
+$2.05M
3
GDDY icon
GoDaddy
GDDY
+$2.02M
4
STZ icon
Constellation Brands
STZ
+$1.93M
5
RHI icon
Robert Half
RHI
+$1.84M

Top Sells

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$2.51M
2
CRM icon
Salesforce
CRM
+$2.17M
3
CSX icon
CSX Corp
CSX
+$1.98M
4
DLTR icon
Dollar Tree
DLTR
+$1.79M
5
MLM icon
Martin Marietta Materials
MLM
+$1.74M

Sector Composition

Rank Sector Weight
1 Technology 19.82%
2 Industrials 15.73%
3 Financials 15.52%
4 Consumer Discretionary 13.8%
5 Healthcare 11.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRMD icon
426
CorMedix
CRMD
$588M
$239K 0.08%
+19,401
New +$214K
RMBS icon
427
Rambus
RMBS
$9.72B
$236K 0.08%
+3,694
New +$198K
CRS icon
428
Carpenter Technology
CRS
$25B
$235K 0.08%
+851
New +$186K
OSIS icon
429
OSI Systems
OSIS
$3.62B
$235K 0.08%
1,045
-1,247
-54% -$266K
TRMB icon
430
Trimble
TRMB
$13.3B
$233K 0.08%
+3,067
New +$206K
MAR icon
431
Marriott International
MAR
$99B
$230K 0.07%
843
-3,231
-79% -$810K
CRNX icon
432
Crinetics Pharmaceuticals
CRNX
$8.85B
$230K 0.07%
+7,990
New +$247K
ARLO icon
433
Arlo Technologies
ARLO
$1.57B
$230K 0.07%
+13,536
New +$173K
TRVI icon
434
Trevi Therapeutics
TRVI
$2.61B
$227K 0.07%
+41,495
New +$258K
TWST icon
435
Twist Bioscience
TWST
$5.69B
$226K 0.07%
+6,143
New +$212K
PYPL icon
436
PayPal
PYPL
$49.3B
$224K 0.07%
3,014
-7,015
-70% -$480K
DDS icon
437
Dillards
DDS
$9.41B
$224K 0.07%
+535
New +$200K
TREX icon
438
Trex
TREX
$4.56B
$223K 0.07%
+4,103
New +$233K
IDT icon
439
IDT Corp
IDT
$1.64B
$223K 0.07%
+3,261
New +$187K
AN icon
440
AutoNation
AN
$7.18B
$222K 0.07%
+1,118
New +$202K
BKV
441
BKV Corp
BKV
$2.63B
$222K 0.07%
+9,196
New +$190K
MTG icon
442
MGIC Investment
MTG
$6.25B
$221K 0.07%
7,925
-63,950
-89% -$1.65M
MXL icon
443
MaxLinear
MXL
$6.07B
$221K 0.07%
+15,520
New +$179K
CACI icon
444
CACI
CACI
$10.5B
$219K 0.07%
+460
New +$204K
AAMI
445
Acadian Asset Management
AAMI
$2.99B
$219K 0.07%
+6,218
New +$181K
OUST icon
446
Ouster
OUST
$2.39B
$219K 0.07%
+9,012
New +$110K
GNW icon
447
Genworth Financial
GNW
$3.81B
$217K 0.07%
+27,897
New +$195K
MEDP icon
448
Medpace
MEDP
$16.1B
$217K 0.07%
+691
New +$207K
VLTO icon
449
Veralto
VLTO
$23.1B
$217K 0.07%
+2,147
New +$207K
ATI icon
450
ATI
ATI
$24.8B
$216K 0.07%
2,506
-10,133
-80% -$694K

Similar funds

AXQ Capital's Q2 2025 Portfolio in Review

As of Q2 2025, AXQ Capital held 817 positions worth $310M, up 24% from $249M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

AXQ Capital deployed $49M of net new capital in Q2 2025, opening 340 new positions and adding to 127 existing holdings. Its largest new stake was Thermo Fisher Scientific: 5,591 shares worth $2.27M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was MGIC Investment, an estimated $1.65M trimmed.

  • AXQ Capital's largest Q2 2025 buy was Thermo Fisher Scientific: 5,591 shares worth $2.27M.
  • AXQ Capital added most to PG&E in Q2 2025, an estimated $2.05M increase.
  • AXQ Capital's biggest Q2 2025 reduction was MGIC Investment, cutting an estimated $1.65M.
  • AXQ Capital fully exited NextEra Energy in Q2 2025, selling an estimated $2.51M.
  • AXQ Capital's ten largest holdings make up 7.4% of its $310M portfolio in Q2 2025.
  • AXQ Capital opened 340 new positions and closed 270 in Q2 2025.
  • AXQ Capital's portfolio value rose 24% quarter-over-quarter to $310M.

Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.